Nanoparticles entering neural retina. Credit: Image provided by Gaurav Sahay, OSU College of Pharmacy Scientists from the Oregon State University College of Pharmacy have demonstrated in animal models the possibility of using lipid nanoparticles and messenger RNA, the technology underpinning COVID-19 vaccines, to treat blindness associated with a rare genetic condition. Researchers developed nanoparticles that […]
12 janvier 2023
Aller à la source The European Times
Author: Oregon State University